Pharmafile Logo
Pharmafocus logo
Advanced Search

community

Showing 5 posts of 5 posts found.

Blog footer

Digital Pharma: Amgen’s online village

June 16, 2010
Medical Communications Amgen, ITP, community, disease awareness campaigns

Amgen has launched an online community for European healthcare professionals, patients and carers affected by autoimmune disease immune thrombycytopenia. Styled …

News
MedUniverse

Digital Pharma: Doctors.net.uk’s Nordic expansion

May 21, 2010
Medical Communications, Sales and Marketing community, digital pharma, doctors.net, meduniverse

UK online doctors network Doctors.net.uk has taken a stake in its Swedish counterpart MedUniverse as part of international expansion plans. …

News
Digital Pharma Guide footer

Pharma’s Digital Revolution – The Story So Far

May 12, 2010
Medical Communications Digital Pharma Guide, FDA, Twitter, blog, community, digital pharma, ipad, social networking

The internet and digital communication are transforming all aspects of pharma’s work. From social media to drug discovery, here are …

Feature
Blog footer

Digital Pharma: Novartis’ transplant community

March 19, 2010
Medical Communications Novartis, PatientsLikeMe, community, digital pharma, digital pharma research, patient information

Novartis has become the second pharma company to partner with PatientsLikeMe on an online community, working with the site on …

News
Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010
Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026